Product
CB-AC-02
1 clinical trial
1 indication
Indication
Alzheimer's DiseaseClinical trial
A Randomized, Double-blind, Placebo-controlled, Phase I / IIa Clinical Trial for Evaluation of Safety and Potential Therapeutic Effect After Transplantation of CB-AC-02 in Patients With Alzheimer's DiseaseStatus: Active (not recruiting), Estimated PCD: 2024-12-01